ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
基本信息
- 批准号:10187409
- 负责人:
- 金额:$ 33.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAstrocytesBrainCell AgingCell CommunicationCell Culture TechniquesCell LineCell modelCellsCerebrumCoculture TechniquesDementiaDiseaseElectrophysiology (science)EnsureEquipmentEthicsFreezingFrontotemporal DementiaGoalsHumanImageInduced pluripotent stem cell derived neuronsInfrastructureInterventionKnowledgeMaintenanceMeasurementMicrogliaModelingMusMycoplasmaNeuronsOnset of illnessOrganoidsParticipantPathway interactionsPatientsPostdoctoral FellowQuarantineReproducibilityResearchResearch PersonnelRoleScientistServicesSourceSpecificityTechnologyTestingTrainingTraining SupportValidationage relatedage related neurodegenerationcell typecellular imagingcombatdisorder controlexperienceinduced pluripotent stem cellmouse modelprogramssenescencestem cell modelstudent trainingtau mutation
项目摘要
PROJECT SUMMARY
The goals of the Program Project are to understand the causes and consequences of cellular senescence as a
driver of age-related neurodegeneration, determine new targets and mechanisms by which senescent cells drive
disease, and identify new targets for interventions that alter disease onset and/or progression. The Alzheimer’s
disease and related dementias (ADRD) induced pluripotent stem cell (iPSC)/organoid core, led by Drs.
Ellerby and Tracy, will provide expertise in generating iPSC-derived neurons, astrocytes, microglia, co-cultures
and brain organoids to understand cellular senescence as a driver of age-related neurodegeneration. It will
provide a suite of iPSC cellular models to all three projects and validate all the derived cell types, co-cultures
and brain organoids. The Core will provide essential infrastructure, training and support for all scientists
participating in the PPG. In addition, it will provide everything needed to culture, conduct electrophysiological
recordings, and image cells. The Core directors have experience in all of these cell manipulations and will
approve all Alzheimer’s-related disease (ARD) and control iPSC models for the facility, including live and frozen
cell cultures from commercial and academic sources, to ensure reproducibility, authentication, testing for
mycoplasma, and other cell line maintenance and validation tasks. These Core directors will approve all
Alzheimer’s disease related and control iPSC models for the facility, including live and frozen cell cultures from
commercial and academic sources, to ensure reproducibility, authentication, testing for mycoplasma, and other
cell line maintenance and validation tasks. The Core will train students and postdoctoral fellows and oversee
any research involving iPSCs that require ESCRO approvals, ethics training and MTAs. To accomplish these
goals, five specific aims of the ‘ADRD iPSC/Organoid Core’ are described. These goals are organized around
the cell type or technology that is needed to address the research questions described in the three projects in
an efficient and optimized approach. The Specific Aims of this Core are: Specific Aim 1 – Generate a bank of
iPSCs derived from the indicated models; Specific Aim 2 – Microglia. Generate microglia from iPSCs derived
from the models (Projects 1, 2 and 3); Specific Aim 3 – Astrocytes. Generate astrocytes from iPSCs derived from
the models (Projects 1 and 3); Specific Aim 4 – Cortical Neurons. Generate cortical neurons (excitatory and
inhibitory) from iPSCs derived from the models (Projects 1, 2 and 3); Specific Aim 5 – Cerebral Organoids and
Co-cultures. Provide cerebral organoids (Projects 1 and 3); Specific Aim 6 – Electrophysiology and Imaging.
We will perform electrophysiological recordings for Projects 1, 2 and 3 in both human cellular models and mouse
models. These aims will provide models and technology that will enhance our knowledge of cell type specificity
and interactions in AD cellular senescence and identify new pathways and targets of opportunity to combat AD
and related dementias.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa M Ellerby其他文献
Lisa M Ellerby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa M Ellerby', 18)}}的其他基金
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
- 批准号:
10491094 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
- 批准号:
10647771 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
ADRD Induced pluripotent stem cell/organoid core
ADRD 诱导多能干细胞/类器官核心
- 批准号:
10491068 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias
细胞衰老和细胞命运/相互作用是阿尔茨海默氏症和年龄相关性痴呆的驱动因素
- 批准号:
10647768 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
Determining the role of OXR1 in aging and Alzheimer's disease
确定 OXR1 在衰老和阿尔茨海默病中的作用
- 批准号:
10461321 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
- 批准号:
10647782 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
Cell autonomous and non-autonomous mechanisms in Alzheimer's disease and related dementias
阿尔茨海默病和相关痴呆的细胞自主和非自主机制
- 批准号:
10187414 - 财政年份:2021
- 资助金额:
$ 33.98万 - 项目类别:
Evaluation of the role of RNA toxicity in SCA2 pathogenesis using genome editing in patient iPSCs
使用患者 iPSC 基因组编辑评估 RNA 毒性在 SCA2 发病机制中的作用
- 批准号:
9803833 - 财政年份:2019
- 资助金额:
$ 33.98万 - 项目类别:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
诱导多能干细胞中模拟人类长寿 ApoE 变异的弹性途径
- 批准号:
9926800 - 财政年份:2018
- 资助金额:
$ 33.98万 - 项目类别:
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
诱导多能干细胞中模拟人类长寿 ApoE 变异的弹性途径
- 批准号:
10417069 - 财政年份:2018
- 资助金额:
$ 33.98万 - 项目类别:














{{item.name}}会员




